Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Abcam Plc ADR (NQ: ABCM )

N/A UNCHANGED
Last Price Updated: 4:00 PM EST, Dec 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 23.74 (1)
Ask (Size) 24.00 (1)
Prev. Close 23.99
Today's Range N/A - N/A
52wk Range 23.92 - 23.99
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Acquisition of Abcam by Danaher Approved by the High Court of Justice of England and Wales
From Abcam plc
Via Business Wire
Abcam PLC (NASDAQ: ABCM) is One of Friday Morning’s Most Active Stocks
Via Investor Brand Network

Performance

More News

Read More
Abcam Acquisition by Danaher Has Received All Identified Clearances; Transaction Expected to Close on December 6, 2023
From Abcam plc
Via Business Wire
Shareholders of Abcam Approve Proposed Acquisition by Danaher
From Abcam plc
Via Business Wire
Abcam PLC (NASDAQ: ABCM) is One of Monday Morning’s Most Active Stocks
Via Investor Brand Network
Health Care Company Danaher Announces Acquisition of Abcam
Via Benzinga
Leading Independent Proxy Advisor Glass Lewis Joins ISS in Recommending Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam
From Abcam plc
Via Business Wire
Leading Proxy Advisor, ISS, Recommends Shareholders Vote “FOR” Danaher Corporation’s Proposed Acquisition of Abcam
From Abcam plc
Via Business Wire
Independent Directors of Abcam Highlight Compelling Reasons for Shareholders to Support Proposed Sale to Danaher
From Abcam
Via Business Wire
ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM
From Kahn Swick & Foti, LLC
Via Business Wire
Abcam Files and Mails Scheme Circular Seeking Approval of Acquisition of Abcam by Danaher for $24.00 per Share
From Abcam plc
Via Business Wire
Danaher Bears The Brunt Of Macro Woes: Analyst Flags Lower Demand, Reduced Funding & Weakness In China
Via Benzinga
Abcam plc Statement on Dr. Jonathan Milner’s Announcement
From Abcam plc
Via Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hostess Brands, Inc. (Nasdaq – TWNK), Avantax, Inc. (Nasdaq – AVTA), Thorne HealthTech, Inc. (Nasdaq - THRN), Abcam plc (Nasdaq - ABCM)
From Brodsky & Smith LLC
Via GlobeNewswire
The 3 Best Pharma Stocks to Buy Now: September 2023
Via InvestorPlace
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Thorne HealthTech, Inc. (Nasdaq - THRN), RPT Realty (NYSE - RPT), Abcam plc (Nasdaq - ABCM)
From Brodsky & Smith LLC
Via GlobeNewswire
Abcam plc Interim Results for the Six-Month Period Ended 30 June 2023
From Abcam plc
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2023
Via Benzinga
ABCAM INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Abcam plc - ABCM
From Kahn Swick & Foti, LLC
Via Business Wire
Danaher's Strategic Abcam Deal Boosts Growth at a Reasonable Price: Analyst
Via Benzinga
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
Via Benzinga
Exposures COVID-19
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Hersha Hospitality Trust (NYSE - HT), Thorne HealthTech, Inc. (Nasdaq - THRN), RPT Realty (NYSE - RPT), Abcam plc (Nasdaq - ABCM)
From Brodsky & Smith LLC
Via GlobeNewswire
ABCM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Abcam plc Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
Danaher Acquires Abcam In $5.7B Deal; ABCM Is Sliding Below Deal Price - Here's Why
Via Benzinga
Danaher to acquire Abcam for $24.00 per Share
From Abcam plc
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.